{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T05:16:21Z","timestamp":1788412581085,"version":"build-2803163510"},"reference-count":37,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T00:00:00Z","timestamp":1743724800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","euoncology.europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Oncology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.euo.2025.03.016","type":"journal-article","created":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T01:13:16Z","timestamp":1746061996000},"page":"17-25","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Prediction of Prostate Cancer Biochemical Recurrence After Radical Prostatectomy by Collagen Models Using Multiomic Profiles"],"prefix":"10.1016","volume":"9","author":[{"given":"Maria","family":"Frantzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Tymoszuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Salcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrique","family":"Gomez-Gomez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana C.","family":"Morillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Melchior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Blanca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Mischak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia","family":"Vlahou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Pircher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Heidegger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euo.2025.03.016_b0005","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.euo.2025.03.016_b0010","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1001\/jama.294.4.433","article-title":"Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy","volume":"294","author":"Freedland","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.euo.2025.03.016_b0015","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.euf.2016.10.007","article-title":"Oncologic outcomes after robot-assisted radical prostatectomy: a large European single-centre cohort with median 10-year follow-up","volume":"4","author":"Rajan","year":"2018","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.euo.2025.03.016_b0020","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.eururo.2018.10.011","article-title":"Prognostic value of biochemical recurrence following treatment with curative intent for prostate cancer: a systematic review","volume":"75","author":"Van den Broeck","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2025.03.016_b0025","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.eururo.2014.09.028","article-title":"The natural history and predictors of outcome following biochemical relapse in the dose escalation era for prostate cancer patients undergoing definitive external beam radiotherapy","volume":"67","author":"Zumsteg","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2025.03.016_b0030","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/s41391-018-0033-1","article-title":"Contemporary approach to predict early biochemical recurrence after radical prostatectomy: update of the Walz nomogram","volume":"21","author":"Pompe","year":"2018","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.euo.2025.03.016_b0035","doi-asserted-by":"crossref","first-page":"5039","DOI":"10.1002\/cncr.26169","article-title":"The CAPRA-S score: a straightforward tool for improved prediction of outcomes after radical prostatectomy","volume":"117","author":"Cooperberg","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.euo.2025.03.016_b0040","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.juro.2012.02.2565","article-title":"A close surgical margin after radical prostatectomy is an independent predictor of recurrence","volume":"188","author":"Lu","year":"2012","journal-title":"J Urol"},{"key":"10.1016\/j.euo.2025.03.016_b0045","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/s41391-022-00544-3","article-title":"The impact of PSMA PET on the treatment and outcomes of men with biochemical recurrence of prostate cancer: a systematic review and meta-analysis","volume":"26","author":"Pozdnyakov","year":"2023","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.euo.2025.03.016_b0050","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.eururo.2024.04.010","article-title":"EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate cancer. Part II\u20142024 update: treatment of relapsing and metastatic prostate cancer","volume":"86","author":"Tilki","year":"2024","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2025.03.016_b0055","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41416-018-0327-z","article-title":"The clinical role of the TME in solid cancer","volume":"120","author":"Giraldo","year":"2019","journal-title":"Br J Cancer"},{"key":"10.1016\/j.euo.2025.03.016_b0060","doi-asserted-by":"crossref","first-page":"8102","DOI":"10.3390\/ijms22158102","article-title":"Inflammation, extracellular matrix remodeling, and proteostasis in tumor microenvironment","volume":"22","author":"Marozzi","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.euo.2025.03.016_b0065","doi-asserted-by":"crossref","first-page":"4364","DOI":"10.1021\/acssensors.4c00585","article-title":"Assessing breast cancer through tumor microenvironment mapping of collagen and other biomolecule spectral fingerprints\u2014a review","volume":"9","author":"Chohan","year":"2024","journal-title":"ACS Sens"},{"key":"10.1016\/j.euo.2025.03.016_b0070","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1186\/s13046-024-03251-0","article-title":"Cancer-associated fibroblasts, tumor and radiotherapy: interactions in the tumor micro-environment","volume":"43","author":"Raaijmakers","year":"2024","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.euo.2025.03.016_b0075","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s10585-019-09966-1","article-title":"The extracellular matrix in tumor progression and metastasis","volume":"36","author":"Eble","year":"2019","journal-title":"Clin Exp Metastasis"},{"key":"10.1016\/j.euo.2025.03.016_b0080","doi-asserted-by":"crossref","unstructured":"Heidegger I, Frantzi M, Salcher S, et al. Prediction of clinically significant prostate cancer by a specific collagen-related transcriptome, proteome, and urinome signature. Eur Urol Oncol. In press. https:\/\/doi.org\/10.1016\/j.euo.2024.05.014.","DOI":"10.1016\/j.euo.2024.05.014"},{"key":"10.1016\/j.euo.2025.03.016_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2018.02.052","article-title":"An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics","volume":"173","author":"Liu","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.euo.2025.03.016_b0090","doi-asserted-by":"crossref","unstructured":"Cancer Genome Atlas Research Network. The molecular taxonomy of primary prostate cancer. Cell 2015;163:1011\u201325.","DOI":"10.1016\/j.cell.2015.10.025"},{"key":"10.1016\/j.euo.2025.03.016_b0095","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.ccell.2018.10.016","article-title":"Molecular evolution of early-onset prostate cancer identifies molecular risk markers and clinical trajectories","volume":"34","author":"Gerhauser","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.euo.2025.03.016_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2019.02.005","article-title":"The proteogenomic landscape of curable prostate cancer","volume":"35","author":"Sinha","year":"2019","journal-title":"Cancer Cell"},{"key":"10.1016\/j.euo.2025.03.016_b0105","doi-asserted-by":"crossref","first-page":"3765","DOI":"10.3390\/cancers14153765","article-title":"Proteomic analysis of prostate cancer FFPE samples reveals markers of disease progression and aggressiveness","volume":"14","author":"Lygirou","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.euo.2025.03.016_b0110","doi-asserted-by":"crossref","first-page":"655","DOI":"10.3390\/diagnostics10090655","article-title":"Molecular changes in tissue proteome during prostate cancer development: proof-of-principle investigation","volume":"10","author":"Latosinska","year":"2020","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.euo.2025.03.016_b0115","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.125638","article-title":"Systems biology identifies cytosolic PLA2 as a target in vascular calcification treatment","volume":"4","author":"Schanstra","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.euo.2025.03.016_b0120","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1038\/s41416-019-0472-z","article-title":"CE-MS-based urinary biomarkers to distinguish non-significant from significant prostate cancer","volume":"120","author":"Frantzi","year":"2019","journal-title":"Br J Cancer"},{"key":"10.1016\/j.euo.2025.03.016_b0125","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.3390\/cancers15041166","article-title":"Mass spectrometry-based biomarkers to detect prostate cancer: a multicentric study based on non-invasive urine collection without prior digital rectal examination","volume":"15","author":"Frantzi","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.euo.2025.03.016_bib167","unstructured":"R Core Team (2023). R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna, Austria."},{"key":"10.1016\/j.euo.2025.03.016_b0130","doi-asserted-by":"crossref","first-page":"768","DOI":"10.18632\/oncotarget.28666","article-title":"Understanding the interplay between extracellular matrix topology and tumor-immune interactions: challenges and opportunities","volume":"15","author":"Fan","year":"2024","journal-title":"Oncotarget"},{"key":"10.1016\/j.euo.2025.03.016_b0135","doi-asserted-by":"crossref","first-page":"10004","DOI":"10.3390\/ijms241210004","article-title":"Reviewing the regulators of COL1A1","volume":"24","author":"Devos","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.euo.2025.03.016_b0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.humpath.2023.09.012","article-title":"Quantification of collagen content and stromal cellularity within reactive stroma is predictive of prostate cancer biochemical recurrence and specific death","volume":"144","author":"Ding","year":"2024","journal-title":"Hum Pathol"},{"key":"10.1016\/j.euo.2025.03.016_bib168","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000032444","article-title":"A pan-cancer analysis of the oncogenic role of procollagen C-endopeptidase enhancer (PCOLCE) in human","volume":"101","author":"Gao","year":"2022","journal-title":"Medicine"},{"key":"10.1016\/j.euo.2025.03.016_b0165","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1186\/s12885-024-12783-9","article-title":"Integrative analysis regarding the correlation between collagen-related genes and prostate cancer","volume":"24","author":"Xiao","year":"2024","journal-title":"BMC Cancer"},{"key":"10.1016\/j.euo.2025.03.016_b0145","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/s41571-024-00967-y","article-title":"Minimal residual disease as a target for liquid biopsy in patients with solid tumours","volume":"22","author":"Pantel","year":"2025","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.euo.2025.03.016_b0150","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.3390\/diagnostics14202293","article-title":"Role of liquid biopsy in progressive PSA patients after radical prostatectomy","volume":"14","author":"Figueras","year":"2024","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.euo.2025.03.016_b0155","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.canlet.2003.11.023","article-title":"Increased cell-free DNA in plasma of patients with metastatic spread in prostate cancer","volume":"205","author":"Jung","year":"2004","journal-title":"Cancer Lett"},{"key":"10.1016\/j.euo.2025.03.016_b0160","doi-asserted-by":"crossref","first-page":"5040","DOI":"10.1038\/s41598-021-84507-z","article-title":"Cell-free DNA concentration and fragment size as a biomarker for prostate cancer","volume":"11","author":"Chen","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.euo.2025.03.016_bib169","doi-asserted-by":"crossref","first-page":"7355","DOI":"10.1038\/s41598-021-86785-z","article-title":"Urinary exosomal microRNA profiling in intermediate-risk prostate cancer","volume":"11","author":"Kim","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.euo.2025.03.016_bib170","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.euf.2017.02.018","article-title":"Diagnostic and Prognostic MicroRNA Biomarkers for Prostate Cancer in Cell-free Urine","volume":"4","author":"Freds\u00f8e","year":"2018","journal-title":"Eur Urol Focus"}],"container-title":["European Urology Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S258893112500094X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S258893112500094X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T20:57:12Z","timestamp":1775681832000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S258893112500094X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S258893112500094X"],"URL":"https:\/\/doi.org\/10.1016\/j.euo.2025.03.016","relation":{},"ISSN":["2588-9311"],"issn-type":[{"value":"2588-9311","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prediction of Prostate Cancer Biochemical Recurrence After Radical Prostatectomy by Collagen Models Using Multiomic Profiles","name":"articletitle","label":"Article Title"},{"value":"European Urology Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euo.2025.03.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V. on behalf of European Association of Urology.","name":"copyright","label":"Copyright"}]}}